The new study, published in Cell Chemical Biology, showed that targeting a key process of how cells make proteins can inhibit cancer cells and resolve what makes them so sensitive. The findings ...

The tumor was putting pressure on multiple of Flores' cranial nerves, said Dr. Mohamed Labib, a neurosurgeon at the University of Maryland Medical Center who led her treatment.

Conclusions: In summary, our study elucidates the mechanism by which ADAR1 deficiency activates anti-tumour immunity and inhibits tumour cell growth. These findings highlight ADAR1 and the downstream ...

However, after years of a steady decline, the Northeast saw a population growth ranging from 0.1% in towns with less than 5,000 people to 1% in towns with populations of 50,000 or more.

Over time, though, is when the real magic happens: Growth factor-mimicking peptides penetrate the skin (10 times deeper than a true growth factor could, by the way) to trigger collagen production.

Type 1 or conventional dendritic cells are known to regulate tumor growth at the primary site of cancer. Immune memory refers to the ability of T cells to remember foreign invaders after previously ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used.

The team of researchers used the gene editing technology CRISPR to convert white fat cells into “beige” fat cells and then implanted the cells in mice models of breast and pancreatic cancer ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor’s cancerous cells influence their surroundings, blocking the body’s immune defenses and creating a sort of haven ...

MICAL2 appears to supercharge the KRAS signaling pathway, which regulates cell growth, proliferation, and death and is known to be the primary driver of pancreatic tumor growth and the spread of ...

"Enzyme promoting tumor growth and spread in pancreatic cancer identified." ScienceDaily. ScienceDaily, 2 January 2025. <www.sciencedaily.com / releases / 2025 / 01 / 250102162505.htm>.

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study by UC San Diego School of Medicine researchers.